Genotypic Technology India

[Dr. Debojyoti Dhar]

Hi!

Greetings from Genotypic Technology, India.

I am Dr Debojyoti Dhar, Head of Global Business at Genotypic Technology.

I am glad to share that we are running a special promotional activity
for Drosophila researchers worldwide who are interested in utilizing the
power of Genomics in their research.

Please feel free to contact Dr Venkatesh, R&D Director, Genotypic
Technology or me for any clarifications.

Let me also take this opportunity to introduce Genotypic Technology :-

*Genotypic Technology* is a 14 year old genomics and bioinformatics
company based in Bangalore, India working with clients world-wide
(academia and industry). Our primary focus is in the applications of
*Next Gen Sequencing (NGS)*, *Microarrays (Agilent certified genomics
service provider)* and *Bioinformatics*.

We are the first in the world to be certified by *Agilent technologies*
for all three major microarray platforms: gene expression, aCGH,
location analysis (ChIP on chip). We are a*ISO 9001:2008* compliant
organization. We are also the first *Certified Service Provider (CSP)
for Ion Torrent sequencing platform in India. *We have profound
scientific strength to help design the most robust, innovative and cost
effective microarray experiments, generate high quality data and most
importantly provide the bioinformatics tools and detailed analysis
reports ready for interpretation and publications. We provide continued
client support at all levels. We have a program called Biointerpreter
that can analyze in hours what would take weeks for microarray data's
biological interpretation.

We have a rich history of clientele both in industry and in academia
that include *Weizmann Institute (Israel), Volcani Centre (Israel),
Evogene (Israel), University of Dundee (Scotland), University of
Liverpool (UK), NUS (Singapore), Weill Cornell Medical College (US),
UCSF (US), Colorado State University (US), John Hopkins University
School of Medicine (US), PepsiCo (US), University of Melbourne
(Australia) *to name a few. Genotypic's collaborative efforts in
research with its global clientele have led to more than 50 publications
in top notch peer reviewed journals and research grants (NIH). Some of
the key publications are as follows:

· Tom Owen Hughes et al.,A role for Snf2-related nucleosome
spacing enzymes. Science (2011), 333(6050):1758-60

· Parag Sadhle et al., UDP-glucose 4, 6-dehydratase activity
plays an important role in maintaining cell wall integrity and virulence
of Candida albicans. PLoS Pathogens (2011), Nov;7(11):e1002384

· Niyaz Ahmed et al., Genome of Multidrug-Resistant
Uropathogenic Escherichia coli Strain NA114 from India. J. Bacteriol
(2011), vol. 193 no. 16 4272-4273

· Mukesh Jain et al., De Novo Assembly of Chickpea Transcriptome
Using Short Reads for Gene Discovery and Marker Identification. DNA Res
(2011), Feb;18(1):53-63

Please visit us at www.genotypic.co.in for more information.

Best Wishes

--
Dr Debojyoti Dhar, PhD,
Senior Manager - Global Business Unit,

Genotypic Technology Pvt. Ltd.
#2/13, Balaji Complex, 80 Feet Road,
R.M.V. Second Stage, Bangalore, INDIA.
Phone: +91 80 40538200, 40538241 (Direct),Mobile-+91 9900035746
Fax: +91 80 40538222
www.genotypic.co.in